ReviewJournal of personalized medicine2021

Non-Covalent BTK Inhibitors-The New BTKids on the Block for B-Cell Malignancies.

Katharine L Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.